Impact of Nonsynonymous Single Nucleotide Polymorphisms on In-Vitro Metabolism of Exemestane by Hepatic Cytosolic Reductases
Pharmacogenetics and Genomics - United States
doi 10.1097/fpc.0000000000000226
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)